Real-time brachytherapy for prostate cancer implant analysis
|
|
- Lynette Price
- 5 years ago
- Views:
Transcription
1 Rep Pract Oncol Radiother, 2008; 13(1): 9-14 Original Paper Received: Accepted: Published: Authors Contribution: A Study Design B Data Collection C Statistical Analysis D Data Interpretation E Manuscript Preparation F Literature Search G Funds Collection Real-time brachytherapy for prostate cancer implant analysis Marta Szlag 1 ABCDEF, Krzysztof Ślosarek 1 ACD, Agata Rembielak 2 ACD, Brygida Białas 2 AD, Marek Fijałkowski 2 B, Joanna Bystrzycka 1 B 1 Department of Treatment Planning, Maria Skłodowska-Curie Memorial Centre of Oncology Institute Gliwice Branch, Gliwice, Poland 2 Department of Brachytherapy, Maria Skłodowska-Curie Memorial Centre of Oncology Institute Gliwice Branch, Gliwice, Poland Summary Background Aim Materials/Methods Results Conclusions Key words In HDR brachytherapy precision of catheter implantation is crucial for conformal treatment planning as a starting point for better optimization process. The aim was to investigate differences between virtual and real needle position and the effect of needle displacement on dosimetric parameters as a function of prostate volume for better evaluation of real implant with respect to final dose distribution. Thirty treatment plans calculated by Nucletron SWIFT were randomly selected. Dosimetric data including V100 for prostate gland and D10 for urethra were analyzed as a function of prostate volume and needle displacement. Needle displacement was determined by measuring the distance between virtual and real positions of respective needles in three sectional images: at the base, apex of the prostate gland and reference image. Dosimetric parameters were determined for consecutive computer plans: virtual (before implantation), live (after implantation and renewed optimization). For the purpose of this study a new parameter, VD (Volume-Dose), was created. VD indicates the quality of real dose distribution with respect to virtual treatment plan. In order to realize the assumption of virtual plan (VD<1) for a given prostate volume, mean values of needle displacement r should not exceed r acceptable according to the formula: r acceptable (Vp) μ Vp 2. For larger glands (above 30cc) final dose distribution is less dependent on needle displacement than smaller ones. The experiment determined maximum values of needle displacement for a given Vp parameter, allowing one to take advantage of optimization algorithms and to improve the final dose distribution. real-time brachytherapy interstitial implant prostate volume 9
2 Original Paper Rep Pract Oncol Radiother, 2008; 13(1): 9-14 Full-text PDF: Word count: 1595 Tables: 1 Figures: 6 References: 10 Author s address: Marta Szlag, Centrum Onkologii Instytut im. Marii Skłodowskiej-Curie, Wybrzeże Armii Krajowej 15 Str., Gliwice Poland, martaszlag@o2.pl BACKGROUND High dose rate brachytherapy has become an incredibly popular method for early-stage prostate cancer [1 3]. In HDR remote afterloading technique the source is positioned inside the catheters in predefined dwell positions. Moreover, the dwell times (time of source stopovers) inside the catheter are individually selected (optimized) for better targeting of the volume of interest as well as sparing normal tissue and organs at risks [4 6]. Additionally, increasingly improved imaging techniques facilitate accurate implantation. Real-time HDR brachytherapy based on transrectal ultrasound guidance provides continuous visualization of the prostate during the treatment planning process [1]. However, in brachytherapy, precision of catheter implantation according to pre-planned needle position and patient s anatomy is crucial for conformal treatment planning and in HDR stepping source technique is a starting point for better optimization process. There is a lack of reports in the literature on the subject of needle displacement as the distance between preplanned catheter position and its real one after implantation, and its impact on the final dose distribution. AIM The aim of this study was to analyze the needle displacement as a function of prostate volume and provide precautions for the needle insertion procedure to improve the quality of the final dose distribution. MATERIALS AND METHODS In the Centre of Oncology MSC Memorial Institute Branch Gliwice patients with early stage localized prostate carcinoma (T1 T2) were treated with combined external beam therapy and HDR 192 Ir brachytherapy from Interstitial brachytherapy of the prostate is delivered as a 10 boost during a single treatment session. Treatment plans are based on transrectal ultrasound imaging and calculated with the Nucletron Swift treatment planning system, which was designed for real time conformal brachytherapy. On the basis of the transverse US images, taken with 1 mm scan thickness, volumes of interest such as PTV and organ at risk (urethra) are reconstructed. According to 3D VOI contours a virtual implant is prepared. Positions of the needles are established with coordinates of the template holes. Dwell positions in each catheter and dwell weights are determined in order to realize the optimal treatment plan. This virtual plan (Figure 1A) is evaluated with parameters of the dose volume histogram V 100 and D 10, which define respectively: the volume of prostate covered by 100% isodose surface, and the dose value that is delivered to 10% volume of the urethra. The implantation procedure is visualized on the live US images, which allow one to control live needle placement according to its virtual coordinates. Insertion of needles always begins with upper right horizontally and ends with lower left corner of the template. Even small differences between prescribed needle position and the real one result in changes in the virtual dose distribution. Therefore, on the basis of real implant geometry, dwell times are recalculated to obtain the final dose distribution ( live treatment plan) (Figure 1B). The quality of the live plan is also evaluated with dosimetric parameters V 100 and D 10. In this study thirty treatment plans ( virtual and live calculated for each patient) were randomly selected for analysis. For each treatment plan differences between virtual and real dose distribution caused by needle displacement were estimated by the new parameter VD (Volume Dose) (eq. 1) VD = V 100 virtual. D (1) 10 live V 100 live D 10 virtual
3 Rep Pract Oncol Radiother, 2008; 13(1): 9-14 Szlag M et al Prostate brachytherapy implant analysis A B Figure 1. Real-time conformal treatment planning for HDR brachytherapy of prostate cancer. (A) virtual treatment plan before implantation based on pre-planned catheter coordinates and anatomy-based optimization, (B) post-implant, final dose distribution calculated for real catheter positions and re-optimized for new implant geometry. Figure 2. The difference between virtual and real needle position r in mm measured on the selected axial image define needle displacement. V 100 virtual and V 100 live are fractions of the prostate volume that are encompassed by 100% isodose in the virtual and real treatment plan, while D 10 virtual and D 10 live are dose values that encompassed 10% volume of the urethra in the virtual and live treatment plan respectively. Values of the provided VD formula, which was created for the purpose of our analysis, characterize the final dose distribution with regard to the virtual plan: When: a. VD<1 real dose distribution is considered to be better than virtual one for prostate gland and/or urethra, b. VD>1 worsening in real dose distribution for prostate gland and/or urethra when compared to virtual plan, c. VD=1 virtual and real treatment plans are considered to be equivalent. Figure 3. Anatomic plane definition. After image acquisition base, reference and apex planes are defined. Apex refers to the plane that intersects the top of the prostate, while the base is the prostate plane closest to the bladder wall; reference is the middle and the largest cross-section of the gland. VD parameter was also designed to compare the differences between real and virtual treatment plans as a function of needle displacement and prostate volume. Needle displacement was determined by measuring the distance between virtual and real positions of respective needles (Figure 2) in three axial images (Figure 3) acquired at the base and the apex of the gland and in the reference image. Mean values of needle displacement were calculated for each plane and for three planes in total. RESULTS Needle number, needle displacement and prostate volume Number of implanted needles varied from 12 to 18 for single real treatment plan and the 11
4 Original Paper Rep Pract Oncol Radiother, 2008; 13(1): 9-14 Figure 4. Number of implanted needles depends on prostate volume Vp parameter. Number of needles and their initial coordinates are established with catheter placement option in treatment planning system on the basis of contoured patient anatomy. Virtual needle position and its number can be modified manually for better PTV coverage. Figure 6. Graph represents the scatter of VD values as a function of prostate volume Vp and needle displacement r. The values of r(vp) (solid line on the graph) boundary represent the maximum acceptable values of mean needle displacement r a and are relative to Vp. Analysis of VD parameter Influence of mean needle displacement and prostate volume on the final dose distribution was analyzed with VD parameter (Figure 6). In the group of treatment plans where VD 1 mean value of prostate volume was observed to be significantly higher than in the group of VD>1, while needle displacement was statistically equal in both groups (Table 1). Figure 5. Mean needle displacement for consecutive number of needle calculated for thirty treatment plans in three axial images. The biggest mean needle displacement was observed in the base plane of the prostate. median needle number was Mean prostate volume considered in this experiment was 29.75cc (±11.9cc). Needle number corresponded with prostate volume. Higher prostate volumes were implanted with higher needle number (Figure 4.) Mean value of the needle displacement r (Figure 2) calculated for thirty live treatment plans was 1.8mm (±0.6 mm) and did not depend on implantation sequence but varied depending on the level of transverse imaging: base, apex or reference. The needle displacement was the smallest for the apex and the biggest for the base plane (Figure 5). Changes in dosimetric parameters between virtual and live plan depend on needle displacement while prostate volume parameter seems to modulate the extent of dose distribution alteration. In order to obtain a real treatment plan at least equivalent to the virtual one, needle displacements for a given prostate volume are required to be equal to or smaller than acceptable, while the acceptable values for a mean needle displacement r are assumed to be determined by the expression: r acceptable (Vp) μ Vp 2 (2) Where: Vp prostate volume in cc by anatomy based contouring of PTV performed on the acquired US slice before implantation. r acceptable prescribed maximum acceptable values of needle displacement for a given Vp value. The expression led to the conclusion that for smaller glands even slight needle shift from 12
5 Rep Pract Oncol Radiother, 2008; 13(1): 9-14 Szlag M et al Prostate brachytherapy implant analysis Table 1. Differences between mean values of geometrical parameters in two groups of VD values. VD 1 n=16 VD>1 n=14 mean ± standard deviation p Mann-Whitney U test Mean needle displacement r [mm] 1.7± ± Prostate volume Vp [cc] 34.25± ± pre-planned positions may affect essential changes in virtual dose distribution that cannot be reduced by re-optimization. DISCUSSION Modern imaging techniques such as transrectal ultrasounds allow visualization of the procedure of implantation and on-line, real time evaluation of the accuracy of needle positioning according to its pre-planned position [7]. Not only for permanent seed implants, careful implant preparation and catheter geometry is an essential part of the treatment planning process in brachytherapy [8,9]. However, the potential tool of dwell time differentiation in HDR stepping source brachytherapy can minimize, to a certain degree, the superfluous underdosed and overdosed volumes resulting from needles displacement from their pre-planned positions. The research into the influence of an adequate needle placement regarding its virtual position as a function of prostate volume improves the possibility of predicting the quality of final dose distribution at the time of implantation. Charra-Brunaud et al. [10] suggested that a higher number of catheters leads to decreasing values of the V 150 parameter (percentage of prostate volume covered with 150% isodose) that allows large high-dose volumes inside the PTV to be avoided. 15 to 21 needles are an adequate number for preparing an optimal treatment plan. The results seems to be in agreement with our study where the number of implanted needles corresponds with prostate volume and was in the range of 12 to 18, which gave sufficient coverage of PTV by reference isodose in the virtual treatment planning phase. In our study the needle implantation sequence was taken into consideration. We assumed that after implantation of consecutive catheters prostate motion would reduce. According to Lagerburg et al. [2] the use of locking needles results in reduced prostate rotation in the coronal plane and thus improves the implantation accuracy. However, in our experiment no significant differences were observed between needle displacement for first and last implanted needles. Thus, during implantation, the prostate movements were not reduced by the increasing number of implanted needles. Implantation sequence or additional locking needles do not influence the reduction of prostate motion. The influence of mean needle displacement on dose distribution depends on prostate volume. Changes of the dose distribution calculated for bigger gland volume are less dependent on the needle shift than for smaller prostates (Figure 4). While mean needle displacement is higher than 2mm, final dose distribution for bigger prostate volumes (30cc) can be equivalent or even better than virtual when the renewed optimization procedure was applied to dose distribution calculated on the basis of real implant geometry. For prostate volumes lower than 25cc even small differences between virtual and real needle positions reduce the effectiveness of optimization methods. If the needle shift exceeds acceptable values for a given Vp parameter, determined by r a (Vp) function, needle relocation during implantation should be considered. Optimization algorithms are beneficial for conformal treatment planning in brachytherapy but their usefulness is restricted by insufficient implant geometry. CONCLUSIONS The calculations demonstrate that final dose distribution depends on needle displacement, which is the distance between virtual and real needle position, but prostate volume should be taken into consideration. The experiment determined maximal values of needle displacement for a given Vp parameter that still allow one to take advantage of optimizations algorithms to improve the final dose distribution. 13
6 Original Paper Rep Pract Oncol Radiother, 2008; 13(1): 9-14 However, acceptable values of needle displacement as a function of prostate volume require further research and more complex and multifactorial analysis. REFERENCES: 1. Kovacs G, Pötter R, Loch T et al: GEC/ESTRO- EAU recommendations on temporary brachytherapy using stepping sources for localized prostate cancer. Radiother Oncol, 2005; 74: Lagerburg V, Moerland MA, Lagendijk JJW, Battermann JJ: Measurement of prostate rotation during insertion of needles for brachytherapy. Radiother Oncol, 2005; 77: Spadinger I, Hilts M, Keyes M et al: Prostate brachytherapy postimplant dosimetry: A comparision of suture embedded and loose seed implants. Brachytherapy, 2006; 5: Sumida I, Shiomi H, Yoshioka Y et al: Optimization of dose distribution for HDR brachytherapy of the prostate using attraction-repulsion model. Int J Radiation Oncology Biol Phys, 2006; 64: Mate TP, Gottesman JE, Hatton J: High Dose Rate Afterloading 192 Ir Prostate Brachytherapy: Feasibility Report. Int J Radiation Oncology Biol Phys, 1998; 41: Martin T, Baltas D, Kurek R et al: 3-D Conformal HDR Brachytherapy as Monotherapy for Localized Prostate Cancer. A Pilot Study. Strahlentherapie und Onkologie, 2004; 180: Fijałkowski M, Białas B, Maciejewski B et al: Three Dimensional (3D) Real Time Conformal Brachytherapy A Novel Solution For Prostate Cancer Treatment. Part I. Rational And Method. Nowotwory Journal of Oncology, 2005; 55: Stone NN, Hong S, Lo Y-C et al: Comparison of intraoperative dosimetric implant representation with postimplant dosimetry in patients receiving prostate brachytherapy. Brachytherapy, 2003; 2: Potters L, Calugaru E, Jassal A, Presser J: Is there a role for postimplant dosimetry after real-time dynamic permanent prostate brachytherapy? Int J Radiation Oncology Biol Phys, 2006; 65: Charra-Brunaud C, Hsu I-C J, Weinberg V, Pouliot J: Analysis of interaction between number of implant catheters and dose volume histograms in prostate high dose rate brachytherapy using a computer model. Int J Radiation Oncology Biol Phys, 2003; 56:
Radiation Planning Index for dose distribution evaluation in stereotactic radiotherapy
Radiation Planning Index for dose distribution evaluation in stereotactic radiotherapy Krzysztof ŚLOSAREK, Aleksandra GRZĄDZIEL, Marta SZLAG, Joanna BYSTRZYCKA Received: 8.4.28 Accepted: 9.8.28 Subject:
More informationRitu Raj Upreti, S. Dayananda, R. L. Bhalawat*, Girish N. Bedre*, D. D. Deshpande
60 Original Article Evaluation of radiograph-based interstitial implant dosimetry on computed tomography images using dose volume indices for head and neck cancer Ritu Raj Upreti, S. Dayananda, R. L. Bhalawat*,
More informationOriginal articles. Abstract. Purpose
Original article Original articles Correlation between treatment plan parameters and particular prognostic factors in prostate cancer treated with high-dose-rate brachytherapy (HDR-BT) as a boost Adam
More informationAbstract Purpose: Material and methods: Results: Conclusions: Key words: Purpose Address for correspondence:
Original paper Physics Contributions The impact of activating source dwell positions outside the CTV on the dose to treated normal tissue volumes in TRUS guided 3D conformal interstitial HDR brachytherapy
More informationTRANSRECTAL ULTRASOUND-GUIDED PROSTATE BRACHYTHERAPY
TRANSRECTAL ULTRASOUND-GUIDED PROSTATE BRACHYTHERAPY 1 TRANSRECTAL ULTRASOUND-GUIDED PROSTATE BRACHYTHERAPY BRENDAN CAREY, MD TRANSRECTAL ULTRASOUND-GUIDED PROSTATE BRACHYTHERAPY 2 TRANSRECTAL ULTRASOUND-GUIDED
More informationCan we deliver the dose distribution we plan in HDR-Brachytherapy of Prostate Cancer?
Can we deliver the dose distribution we plan in HDR-Brachytherapy of Prostate Cancer? Dimos Baltas Dept. of Medical Physics & Engineering, Strahlenklinik, Klinikum Offenbach GmbH 63069 Offenbach, Germany
More information20 Prostate Cancer Dan Ash
20 Prostate Cancer Dan Ash 1 Introduction Prostate cancer is a disease of ageing men for which the aetiology remains unknown. The incidence rises up to 30 to 40% in men over 80. The symptoms of localised
More informationCan we deliver the dose distribution we plan in HDR-Brachytherapy of Prostate Cancer?
Can we deliver the dose distribution we plan in HDR-Brachytherapy of Prostate Cancer? Dimos Baltas 1,3, Natasa Milickovic 1, Nikolaos Zamboglou 2 1 Dept. of Medical Physics & Engineering, 2 Strahlenklinik,
More informationVital role of volume and number of needles in HDR brachytherapy (HDR-BT) of prostate cancer
Original article Clinical Investigations Vital role of volume and number of needles in HDR brachytherapy (HDR-BT) of prostate cancer Adam Chichel/, MD, Marek Kanikowski, MD, Janusz Skowronek, MD, PhD,
More informationDOSIMETRIC OPTIONS AND POSSIBILITIES OF PROSTATE LDR BRACHYTHERAPY WITH PERMANENT I-125 IMPLANTS
DOSIMETRIC OPTIONS AND POSSIBILITIES OF PROSTATE LDR BRACHYTHERAPY WITH PERMANENT I-125 IMPLANTS Andrius IVANAUSKAS*, Eduardas ALEKNAVIČIUS*, Arvydas BURNECKIS*, Albert MILLER *Institute of Oncology Vilnius
More informationQuality Assurance of TPS: comparison of dose calculation for stereotactic patients in Eclipse and iplan RT Dose
Petrovic B Comparison of dose calculation algorithms for stereotaxy Quality Assurance of TPS: comparison of dose calculation for stereotactic patients in and RT Dose Borislava Petrovic 1, Aleksandra Grządziel
More informationContent. Acknowledgments. Prostate brachy LDR Prostate brachy HDR. Use of permanent seeds and HDR in prostate: Current practice and advances
IRIMED Use of permanent seeds and HDR in prostate: Current practice and advances Content Prostate brachy LDR Prostate brachy HDR Jose Perez-Calatayud Hospital Universitario y Politecnico La Fe. Valencia.
More informationBrachytherapy Planning and Quality Assurance w Classical implant systems and modern computerized dosimetry w Most common clinical applications w
Brachytherapy Planning and Quality Assurance w Classical implant systems and modern computerized dosimetry w Most common clinical applications w Quality assurance Classical implant systems w Manchester
More informationBrachytherapy Planning and Quality Assurance
Brachytherapy Planning and Quality Assurance Classical implant systems Most common clinical applications and modern dosimetry methods Quality assurance Classical implant systems Manchester (Paterson-Parker)
More informationQuality Assurance of Ultrasound Imaging in Radiation Therapy. Zuofeng Li, D.Sc. Murty S. Goddu, Ph.D. Washington University St.
Quality Assurance of Ultrasound Imaging in Radiation Therapy Zuofeng Li, D.Sc. Murty S. Goddu, Ph.D. Washington University St. Louis, Missouri Typical Applications of Ultrasound Imaging in Radiation Therapy
More information3D ANATOMY-BASED PLANNING OPTIMIZATION FOR HDR BRACHYTHERAPY OF CERVIX CANCER
SAUDI JOURNAL OF OBSTETRICS AND GYNECOLOGY VOLUME 11 NO. 2 1430 H - 2009 G 3D ANATOMY-BASED PLANNING OPTIMIZATION FOR HDR BRACHYTHERAPY OF CERVIX CANCER DR YASIR BAHADUR 1, DR CAMELIA CONSTANTINESCU 2,
More informationMEDICAL POLICY. SUBJECT: BRACHYTHERAPY OR RADIOACTIVE SEED IMPLANTATION FOR PROSTATE CANCER POLICY NUMBER: CATEGORY: Technology Assessment
MEDICAL POLICY SUBJECT: BRACHYTHERAPY OR PAGE: 1 OF: 5 If the member's subscriber contract excludes coverage for a specific service it is not covered under that contract. In such cases, medical policy
More informationTrina Lynd, M.S. Medical Physicist Lifefirst Imaging & Oncology Cullman, AL Tri-State Alabama, Louisiana and Mississippi Spring 2016 Meeting April
Trina Lynd, M.S. Medical Physicist Lifefirst Imaging & Oncology Cullman, AL Tri-State Alabama, Louisiana and Mississippi Spring 2016 Meeting April 17, 2016 Discuss permanent prostate brachytherapy and
More informationEvaluation of Normal Tissue Complication Probability and Risk of Second Primary Cancer in Prostate Radiotherapy
Evaluation of Normal Tissue Complication Probability and Risk of Second Primary Cancer in Prostate Radiotherapy Rungdham Takam Thesis submitted for the degree of Doctor of Philosophy in The School of Chemistry
More informationJOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 6, NUMBER 2, SPRING 2005
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 6, NUMBER 2, SPRING 2005 Advantages of inflatable multichannel endorectal applicator in the neo-adjuvant treatment of patients with locally advanced
More informationCatheter displacement prior to the delivery of high-dose-rate brachytherapy in the treatment of prostate cancer patients
Original paper Clinical Investigations Catheter displacement prior to the delivery of high-dose-rate brachytherapy in the treatment of prostate cancer patients Shogo Kawakami, MD 1, Hiromichi Ishiyama,
More informationMeasurement of craniocaudal catheter displacement between fractions in computed tomography based high dose rate brachytherapy of prostate cancer
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 8, NUMBER 4, FALL 2007 Measurement of craniocaudal catheter displacement between fractions in computed tomography based high dose rate brachytherapy
More informationHDR vs. LDR Is One Better Than The Other?
HDR vs. LDR Is One Better Than The Other? Daniel Fernandez, MD, PhD 11/3/2017 New Frontiers in Urologic Oncology Learning Objectives Indications for prostate brachytherapy Identify pros/cons of HDR vs
More informationMEDICAL POLICY SUBJECT: BRACHYTHERAPY OR RADIOACTIVE SEED IMPLANTATION FOR PROSTATE CANCER
MEDICAL POLICY SUBJECT: BRACHYTHERAPY OR PAGE: 1 OF: 6 If the member's subscriber contract excludes coverage for a specific service it is not covered under that contract. In such cases, medical policy
More information3D CONFORMATIONAL INTERSTITIAL BRACHYTHERAPY PLANNING FOR SOFT TISSUE SARCOMA
3D CONFORMATIONAL INTERSTITIAL BRACHYTHERAPY PLANNING FOR SOFT TISSUE SARCOMA Alina TĂNASE 1,3, M. DUMITRACHE 2,3, O. FLOREA 1 1 Emergency Central Military Hospital Dr. Carol Davila Bucharest, Romania,
More informationComparison of two techniques of interstitial pulsed dose rate boost brachytherapy in conservative treatment of breast cancer
Original article Original articles Comparison of two techniques of interstitial pulsed dose rate boost brachytherapy in conservative treatment of breast cancer Krystyna Serkies, MD, PhD 1, Zofia Tarnawska,
More informationDefinitions. Brachytherapy in treatment of cancer. Implantation Techniques and Methods of Dose Specifications. Importance of Brachytherapy in GYN
Implantation Techniques and Methods of Dose Specifications Brachytherapy Course Lecture V Krishna Reddy, MD, PhD Assistant Professor, Radiation Oncology Brachytherapy in treatment of cancer GYN Cervical
More informationAssessment of dose homogeneity in conformal interstitial breast brachytherapy with special respect to ICRU recommendations
Physics Contributions Original article Assessment of dose homogeneity in conformal interstitial breast brachytherapy with special respect to ICRU recommendations Tibor Major, PhD, Georgina Fröhlich, PhD,
More informationVenezia Advanced Gynecological Applicator Reaching beyond
Venezia Advanced Gynecological Applicator Reaching beyond Advanced Gynecological Applicator Venezia is FDA cleared and CE marked, but is not available in all markets. 1 Helping clinicians improve patients
More informationStereotactic radiosurgery of prostate cancer dose distribution for VMAT and CyberKnife techniques
Polish Journal of Medical Physics and Engineering 2016;22(2):35-40 doi: 10.1515/pjmpe-2016-0007 Scientific Paper Stereotactic radiosurgery of prostate cancer dose distribution for VMAT and CyberKnife techniques
More informationEvaluation of three APBI techniques under NSABP B-39 guidelines
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 11, NUMBER 1, WINTER 2010 Evaluation of three APBI techniques under NSABP B-39 guidelines Daniel Scanderbeg, a Catheryn Yashar, Greg White, Roger Rice,
More informationBrachytherapy an Overview
Brachytherapy an Overview Yakov Pipman, D Sc North Shore LIJ Health System Monterrey, Nov30-Dec1, 2007 Brachytherapy A procedure in therapeutic radiology that involves the irradiation of a target with
More informationThe benefit of a preplanning procedure - view from oncologist. Dorota Kazberuk November, 2014 Otwock
The benefit of a preplanning procedure - view from oncologist Dorota Kazberuk 21-22 November, 2014 Otwock Brachytherapy is supreme tool in prostate cancer management with a wide range of options in every
More informationInterim Report. Prostate Cancer Fight Foundation Motorcycle Ride for Dad. February 7, Supporting Kingston s university hospitals:
Interim Report Prostate Cancer Fight Foundation Motorcycle Ride for Dad February 7, 2014 Supporting Kingston s university hospitals: Thank you for your continued support of prostate cancer research in
More informationComparison of IPSA and HIPO inverse planning optimization algorithms for prostate HDR brachytherapy
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 15, NUMBER 6, 2014 Comparison of IPSA and HIPO inverse planning optimization algorithms for prostate HDR brachytherapy Vanessa Panettieri, 1a Ryan L.
More informationUltrasoundeCT fusion compared with MReCT fusion for postimplant dosimetry in permanent prostate brachytherapy
Brachytherapy 12 (2013) 38e43 UltrasoundeCT fusion compared with MReCT fusion for postimplant dosimetry in permanent prostate brachytherapy David Bowes 1, Juanita M. Crook 2, *, Cynthia Araujo 3, Deidre
More informationHigh-dose-rate brachytherapy delivered in two fractions as monotherapy for low-risk prostate cancer
Original paper Clinical Investigations High-dose-rate brachytherapy delivered in two fractions as monotherapy for low-risk prostate cancer Ricardo Cendales, MD, MSc, Elizabeth Alwers, MD, MSc, Javier Cifuentes,
More informationReview of brachytherapy in
Medical Physics in the Baltic States 2017 Review of brachytherapy in Klaipėda University Hospital Romas Vilkas Rasa Dagienė Klaipėda University Hospital 1 Aims of presentation: To show progress of brachytherapy
More informationResults of interstitial HDR brachytherapy for cancer of the lower lip
Original Paper Received: 2005.01.06 Accepted: 2005.05.13 Published: 2005.09.20 Results of interstitial HDR brachytherapy for cancer of the lower lip Andrzej Lebioda 1,2, Roman Makarewicz 1,2, Joanna Terlikiewicz
More informationPROSTATE CANCER BRACHYTHERAPY. Kazi S. Manir MD,DNB,PDCR RMO cum Clinical Tutor Department of Radiotherapy R. G. Kar Medical College
PROSTATE CANCER BRACHYTHERAPY Kazi S. Manir MD,DNB,PDCR RMO cum Clinical Tutor Department of Radiotherapy R. G. Kar Medical College Risk categorization Very Low Risk Low Risk Intermediate Risk High Risk
More informationHDR Brachytherapy: Results and Future Studies in Monotherapy
HDR Brachytherapy: Results and Future Studies in Monotherapy Nikolaos Zamboglou and Nikolaos Tselis Strahlenklinik Klinikum Offenbach - Germany Prostate Brachytherapy UK & Ireland Conference 2013 Comparison
More informationPermanent Prostate Brachytherapy Post Procedure Evaluation
Permanent Prostate Brachytherapy Post Procedure Evaluation William S. Bice, Jr., Ph.D. UTHSCSA, San Antonio, Texas IMPS, San Antonio, Texas Texas Cancer Clinic, San Antonio, Texas Implant Evaluation for
More informationAdvances in Treatment of Cancer by Brachytherapy in Kenya, in Particular, Prostate Cancer
Research Article imedpub Journals www.imedpub.com Journal Of Medical Physics And Applied Sciences ISSN 2574-285X DOI: 1.21767/2574-285X.12 Advances in Treatment of Cancer by Brachytherapy in Kenya, in
More informationBRACHYTHERAPY IN HORSES
Vet Times The website for the veterinary profession https://www.vettimes.co.uk BRACHYTHERAPY IN HORSES Author : DAVID DONALDSON Categories : Vets Date : June 16, 2014 DAVID DONALDSON BVSc(Hons), DipECVO,
More informationA TREATMENT PLANNING STUDY COMPARING VMAT WITH 3D CONFORMAL RADIOTHERAPY FOR PROSTATE CANCER USING PINNACLE PLANNING SYSTEM *
Romanian Reports in Physics, Vol. 66, No. 2, P. 394 400, 2014 A TREATMENT PLANNING STUDY COMPARING VMAT WITH 3D CONFORMAL RADIOTHERAPY FOR PROSTATE CANCER USING PINNACLE PLANNING SYSTEM * D. ADAM 1,2,
More informationAcknowledgements. QA Concerns in MR Brachytherapy. Learning Objectives. Traditional T&O. Traditional Summary. Dose calculation 3/7/2015
Acknowledgements QA Concerns in MR Brachytherapy Robert A. Cormack Dana Farber Cancer Institute & Brigham and Women s Hospital No financial conflicts of interest I may mention use of devices in ways that
More informationSASCRO Prostate Brachytherapy Guidelines Task Group
SASCRO Prostate Brachytherapy Guidelines Task Group Anderson D 1, N Coetzee 2,Du Toit PD 3, Webb G 4 1Radiation Oncologist, Groote Schuur Hospital. 2Medical Physicist, Equra Health 3Medical Physicist,
More informationRecent proceedings in Brachytherapy Physics
Recent proceedings in Brachytherapy Physics Frank-André Siebert UKSH, Campus Kiel, Germany Clinic of Radiotherapy Dept. Medical Physics Physical characteristics of brachytherapy (Courtesy Luc Beaulieu,
More informationOnline in vivo dosimetry in conformal radiotherapies with MOSkin detectors
Online in vivo dosimetry in conformal radiotherapies with MOSkin detectors G.Gambarini 1, C.Tenconi 1, N.Mantaut 1 M.Carrara 2, M.Borroni 2, E.Pignoli 2 D.Cutajar 3, M.Petasecca 3, I.Fuduli 3, M.Lerch
More informationPatient Safety Focused QA. LDR Brachytherapy Vrinda Narayana
Patient Safety Focused QA LDR Brachytherapy Vrinda Narayana D < 2 Gy/h Old LDR Brachytherapy? Ra-226; Cs-137; Ir-192 New Gynecological; interstitial Pd-103; I-125; Cs-131 Prostate implants Eye plaques
More informationHigh dose rate brachytherapy as monotherapy for localised prostate cancer: a hypofractionated two-implant approach in 351 consecutive patients
High dose rate brachytherapy as monotherapy for localised prostate cancer: a hypofractionated two-implant approach in 351 consecutive patients Tselis et al. Tselis et al. Radiation Oncology 213, 8:115
More informationFeasibility of 4D IMRT Delivery for Hypofractionated High Dose Partial Prostate Treatments
Feasibility of 4D IMRT Delivery for Hypofractionated High Dose Partial Prostate Treatments R.A. Price Jr., Ph.D., J. Li, Ph.D., A. Pollack, M.D., Ph.D.*, L. Jin, Ph.D., E. Horwitz, M.D., M. Buyyounouski,
More informationFEE RULES RADIATION ONCOLOGY FEE SCHEDULE CONTENTS
Tel: +27-21-9494060 Fax: +27-21-9494112 E-mail: leon.gouws@cancercare.co.za FEE RULES RADIATION ONCOLOGY FEE SCHEDULE CONTENTS 1. EXTERNAL BEAM RADIATION... 2 2. PLANNING OF TREATMENT... 2 3. DELIVERY
More informationRadiation Therapy for Prostate Cancer. Resident Dept of Urology General Surgery Grand Round November 24, 2008
Radiation Therapy for Prostate Cancer Amy Hou,, MD Resident Dept of Urology General Surgery Grand Round November 24, 2008 External Beam Radiation Advances Improving Therapy Generation of linear accelerators
More informationQuality management for Breast Brachytherapy.
Quality management for Breast Brachytherapy. DORIN TODOR, Ph.D. Medical College of Virginia Campus Department of Radiation Oncology New England AAPM Chapter 2012 Summer Meeting, Providence, RI Quality
More informationTransperineal Interstitial Permanent Prostate Brachytherapy (TIPPB) Quality Assurance Guidelines
Prostate Brachytherapy QA Page 1 of 1 Transperineal Interstitial Permanent Prostate Brachytherapy (TIPPB) Quality Assurance Guidelines I. Purpose Table of Contents II. III. IV. Background Credentialing
More informationOPTIMIZATION OF COLLIMATOR PARAMETERS TO REDUCE RECTAL DOSE IN INTENSITY-MODULATED PROSTATE TREATMENT PLANNING
Medical Dosimetry, Vol. 30, No. 4, pp. 205-212, 2005 Copyright 2005 American Association of Medical Dosimetrists Printed in the USA. All rights reserved 0958-3947/05/$ see front matter doi:10.1016/j.meddos.2005.06.002
More informationDosimetric Analysis of 3DCRT or IMRT with Vaginal-cuff Brachytherapy (VCB) for Gynaecological Cancer
Dosimetric Analysis of 3DCRT or IMRT with Vaginal-cuff Brachytherapy (VCB) for Gynaecological Cancer Tan Chek Wee 15 06 2016 National University Cancer Institute, Singapore Clinical Care Education Research
More informationEPID dosimetry confi guration and pre-treatment IMRT verifi cation
Rep Pract Oncol Radiother, 2007; 12(6): 307-312 Original Paper Received: 2007.04.26 Accepted: 2007.08.29 Published: 2007.12.27 Authors Contribution: A Study Design B Data Collection C Statistical Analysis
More informationDosimetric effects of prone and supine positions on post-implant assessments for prostate brachytherapy
Original paper Clinical Investigations Dosimetric effects of prone and supine positions on post-implant assessments for prostate brachytherapy Toshio Ohashi, MD, PhD 1,2, Tetsuo Momma, MD, PhD 3, Shoji
More informationHigh-Dose Rate Temporary Prostate Brachytherapy. Original Policy Date
MP 8.01.15 High-Dose Rate Temporary Prostate Brachytherapy Medical Policy Section Therapy Issue 12/2013 Original Policy Date 12/2013 Last Review Status/Date Reviewed with literature search/12/2013 Return
More informationJean Pouliot, PhD Professor and Vice Chair, Department of Radiation Oncology, Director of Physics Division
IMRT / Tomo / VMAT / Cyberknife / HDR Brachytherapy: Jean Pouliot, PhD Professor and Vice Chair, Department of Radiation Oncology, Director of Physics Division Should Choices be Based on Dosimetric and
More informationOutline - MRI - CT - US. - Combinations of imaging modalities for treatment planning
Imaging Outline - MRI - CT - US - Combinations of imaging modalities for treatment planning Imaging Part 1: MRI MRI for cervical cancer high soft tissue contrast multiplanar imaging MRI anatomy: the normal
More informationBrachytherapy The use of radioactive sources in close proximity to the target area for radiotherapy
Brachytherapy The use of radioactive sources in close proximity to the target area for radiotherapy Interstitial Seven 192-Ir wires Interstitial implant for breast radiotherapy Intracavitary Three 137-Cs
More informationStepping source prostate brachytherapy: From target definition to dose delivery Dinkla, A.M.
UvA-DARE (Digital Academic Repository) Stepping source prostate brachytherapy: From target definition to dose delivery Dinkla, A.M. Link to publication Citation for published version (APA): Dinkla, A.
More informationImage based Brachytherapy- HDR applications in Gynecological Tumors
Image based Brachytherapy- HDR applications in Gynecological Tumors Yakov Pipman, D. Sc. North Shore LIJ Health System Sites amenable to treatment with HDR Brachytherapy GYN Breast Prostate Head and Neck
More informationVarian Acuity BrachyTherapy Suite One Room Integrated Image-Guided Brachytherapy
Varian Acuity BrachyTherapy Suite One Room Integrated Image-Guided Brachytherapy The Acuity BrachyTherapy Suite Integrating Imaging, Planning, and Treatment in a Single Room Each component draws on the
More informationDoes the IMRT technique allow improvement of treatment plans (e.g. lung sparing) for lung cancer patients with small lung volume: a planning study
Does the IMRT technique allow improvement of treatment plans (e.g. lung sparing) for lung cancer patients with small lung volume: a planning study Received: 22.04.2008 Accepted: 4.07.2008 Subject: original
More informationINTRODUCTION PATIENT. J. Radiat. Res., 52, (2011)
J. Radiat. Res., 52, 54 58 (2011) Regular Paper Intracavitary Combined with CT-guided Interstitial Brachytherapy for Locally Advanced Uterine Cervical Cancer: Introduction of the Technique and a Case Presentation
More informationHigh-dose-rate brachytherapy as monotherapy for prostate cancer: technique, rationale and perspective
Review paper Educational Activity High-dose-rate brachytherapy as monotherapy for prostate cancer: technique, rationale and perspective Yasuo Yoshioka, MD, PhD 1, Osamu Suzuki, MD, PhD 1, Yuki Otani, PhD
More informationAnalysis on the Reporting of Medical Events in Permanent Prostate Brachytherapy
Open Access Original Article DOI: 10.7759/cureus.133 Analysis on the Reporting of Medical Events in Permanent Prostate Brachytherapy Wanbao Gao1 1. Southern Advanced Medical Physics, Inc. Corresponding
More informationCyberKnife Monotherapy for Prostate Cancer
C H A P T E R 29 CyberKnife Monotherapy for Prostate Cancer Clinton A. Medbery Marianne M. Young Astrid E. Morrison J. Stephen Archer Maximian F. D Souza Cindy Parry Abstract The purpose of our planned
More informationLDR Monotherapy vs. HDR Monotherapy
Abstract No. 1234 LDR Monotherapy vs. HDR Monotherapy Is it time for LDR to retire? Gerard Morton 2 LDR Seed Brachytherapy First 2000 LDR patients from BCCA Low and Intermediate Risk LDR Implant Morris
More informationLeila E. A. Nichol Royal Surrey County Hospital
2 nd UK and Ireland Dosimetry Check User Meeting Symposium Clatterbridge Cancer Centre, 24 th October 2012 Leila E. A. Nichol Royal Surrey County Hospital Leila.Nichol@nhs.net *My experience with Dosimetry
More informationI. Equipments for external beam radiotherapy
I. Equipments for external beam radiotherapy 5 linear accelerators (LINACs): Varian TrueBeam 6, 10 & 18 MV photons, 6-18 MeV electrons, image-guided (IGRT) and intensity modulated radiotherapy (IMRT),
More informationSUPERIORITY OF A REAL TIME PLANNING TECHNIQUE OVER IMAGE GUIDED RADIATION THERAPY FOR THE TREATMENT OF PRIMARY PROSTATE CANCERS
SUPERIORITY OF A REAL TIME PLANNING TECHNIQUE OVER IMAGE GUIDED RADIATION THERAPY FOR THE TREATMENT OF PRIMARY PROSTATE CANCERS Authors: Scott Merrick James Wong MD, Mona Karim MD, Yana Goldberg MD DISCLOSURE
More informationUsing Task Group 137 to Prescribe and Report Dose. Vrinda Narayana. Department of Radiation Oncology University of Michigan. The
Using Task Group 137 to Prescribe and Report Dose Vrinda Narayana The Department of Radiation Oncology University of Michigan TG137 AAPM Recommendations on Dose Prescription and Reporting Methods for Permanent
More informationA new homogeneity index based on statistical analysis of the dose volume histogram
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 8, NUMBER 2, SPRING 2007 A new homogeneity index based on statistical analysis of the dose volume histogram Myonggeun Yoon, Sung Yong Park, a Dongho
More informationAccurate Accurate boost or Simply Accuboost
Accurate Accurate boost or Simply Accuboost Zoubir Ouhib MS DABR Lynn Cancer Institute of Boca Raton Community Hospital Disclosure: Advisory board Items to be discussed Big picture on management of Breast
More informationor low dose rate (LDR), brachytherapy
High dose rate brachytherapy for prostate cancer: Current techniques and applications to varying disease presentations Daniel J. Krauss, MD High dose rate (HDR) brachytherapy has been an option for managing
More informationDosimetric Analysis Report
RT-safe 48, Artotinis str 116 33, Athens Greece RT-safe +30 2107563691 info@rt-safe.com Dosimetric Analysis Report SAMPLE, for demonstration purposes only Date of report: ------ Irradiation system: ------
More informationRegulatory Guidelines and Computational Methods for Safe Release of Radioactive Patients II. Brachytherapy
Regulatory Guidelines and Computational Methods for Safe Release of Radioactive Patients II. Brachytherapy Firas Mourtada, Ph.D., DABR Chief of Clinical Physics Helen F. Graham Cancer Center Christiana
More informationOutline. Chapter 12 Treatment Planning Combination of Beams. Opposing pairs of beams. Combination of beams. Opposing pairs of beams
Chapter 12 Treatment Planning Combination of Beams Radiation Dosimetry I Text: H.E Johns and J.R. Cunningham, The physics of radiology, 4 th ed. http://www.utoledo.edu/med/depts/radther Outline Combination
More informationAdvanced Technology Consortium (ATC) Credentialing Procedures for 3D Conformal Therapy Protocols 3D CRT Benchmark*
Advanced Technology Consortium (ATC) Credentialing Procedures for 3D Conformal Therapy Protocols 3D CRT Benchmark* Purpose: To evaluate an institution s 3D treatment planning process and the institution
More informationMedical Policy. MP High-Dose Rate Temporary Prostate Brachytherapy
Medical Policy MP 8.01.33 BCBSA Ref. Policy: 8.01.33 Last Review: 07/25/2018 Effective Date: 07/25/2018 Section: Therapy Related Policies 7.01.79 Cryoablation of Prostate Cancer 8.01.10 Charged-Particle
More informationCLINICAL WORKSHOP IMAGE-GUIDED HDR BRACHYTHERAPY OF PROSTATE CANCER
CLINICAL WORKSHOP IMAGE-GUIDED HDR BRACHYTHERAPY OF PROSTATE CANCER Klinikum Offenbach Nucletron April 27 th 28 th, 2014 History HDR Protocols for Boost and Monotherapy, Results, Logistics and Practical
More informationINTRAOPERATIVE DYNAMIC DOSE OPTIMIZATION IN PERMANENT PROSTATE IMPLANTS EVA K. LEE, PH.D.,* AND MARCO ZAIDER, PH.D.
doi:10.1016/s0360-3016(03)00291-8 Int. J. Radiation Oncology Biol. Phys., Vol. 56, No. 3, pp. 854 861, 2003 Copyright 2003 Elsevier Inc. Printed in the USA. All rights reserved 0360-3016/03/$ see front
More informationComprehensive and Practical Brachytherapy March 04-8 March 2018, Ljubljana, Slovenia Day 1 Sunday 4 March 2018
Day 1 Sunday 4 March 2018 Welcome and Summary of the course 13:00-13:20 15 introduction 13:20-13:50 30 Radioactivity Radioactivity: What we need to know Characteristics of LDR-PDR-HDR, radiobiological
More informationADVANCED TECHNOLOGY CONSORTIUM (ATC) CREDENTIALING PROCEDURES FOR LUNG BRACHYTHERAPY IMPLANT PROTOCOLS
ACOSOG-RTOG Lung Brachytherapy QA Page 1 of 8 ADVANCED TECHNOLOGY CONSORTIUM (ATC) CREDENTIALING PROCEDURES FOR LUNG BRACHYTHERAPY IMPLANT PROTOCOLS FACILITY QUESTIONNAIRE Institutions wishing to enter
More informationNIA MAGELLAN HEALTH RADIATION ONCOLOGY CODING STANDARD. Dosimetry Planning
NIA MAGELLAN HEALTH RADIATION ONCOLOGY CODING STANDARD Dosimetry Planning CPT Codes: 77295, 77300, 77301, 77306, 77307, 77321, 77316, 77317, 77318, 77331, 77399 Original Date: April, 2011 Last Reviewed
More informationHow ICD-10 Affects Radiation Oncology. Presented by, Lashelle Bolton CPC, COC, CPC-I, CPMA
How ICD-10 Affects Radiation Oncology Presented by, Lashelle Bolton CPC, COC, CPC-I, CPMA ICD-10 ICD-10-CM has added new challenges to the radiation oncology specialty. Approximately 220 ICD-9-CM codes
More informationDosimetric impact of cylinder size in high-dose rate vaginal cuff brachytherapy (VCBT) for primary endometrial cancer
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 17, NUMBER 5, 2016 Dosimetric impact of cylinder size in high-dose rate vaginal cuff brachytherapy (VCBT) for primary endometrial cancer Hualin Zhang,
More informationGdansk, Poland Gdansk, Poland
Radiation Protection Dosimetry (2006), Vol. 120, No. 1 4, pp. 171 175 doi:10.1093/rpd/nci528 Advance Access published on March 24, 2006 EPR/ALANINE DOSIMETRY IN LDR BRACHYTHERAPY A FEASIBILITY STUDY Katarzyna
More informationREVISITING ICRU VOLUME DEFINITIONS. Eduardo Rosenblatt Vienna, Austria
REVISITING ICRU VOLUME DEFINITIONS Eduardo Rosenblatt Vienna, Austria Objective: To introduce target volumes and organ at risk concepts as defined by ICRU. 3D-CRT is the standard There was a need for a
More informationThe Impact of Image Guided Radiotherapy in Breast Boost Radiotherapy
The Impact of Image Guided Radiotherapy in Breast Boost Radiotherapy 1 Donovan EM, 1 Brooks C, 1 Mitchell A, 2 Mukesh M, 2 Coles CE, 3 Evans PM, 1 Harris EJ 1 Joint Department of Physics, The Royal Marsden/Institute
More information2015 Radiology Coding Survival Guide
2015 Radiology Coding Survival Guide Chapter 31: Clinical Brachytherapy (77750-77799) Clinical brachytherapy involves applying radioelements into or around a treatment field. CPT guidelines clarify that
More informationEfficient SIB-IMRT planning of head & neck patients with Pinnacle 3 -DMPO
Investigations and research Efficient SIB-IMRT planning of head & neck patients with Pinnacle 3 -DMPO M. Kunze-Busch P. van Kollenburg Department of Radiation Oncology, Radboud University Nijmegen Medical
More informationProstate Cancer. What is prostate cancer?
Scan for mobile link. Prostate Cancer Prostate cancer is a tumor of the prostate gland, which is located in front of the rectum and below the bladder. Your doctor may perform a physical exam, prostate-specific
More informationCone-beam CT-based adaptive planning improves permanent prostate brachytherapy dosimetry: An analysis of 1266 patients
Cone-beam CT-based adaptive planning improves permanent prostate brachytherapy dosimetry: An analysis of 1266 patients Hendrik Westendorp a) Department of Medical Physics, Department of Radiation Oncology,
More information